Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Gojo

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Thoracic t(9;22)-positive granulocytic sarcoma as initial presentation of chronic myeloid leukemiaMhairi Mitchell, Doha Itani, Jonathan Gerber, et al.
Leukemia & Lymphoma|June 4, 2013
Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemiaYi Ning, Marilyn L Slovak, Roger A Schultz, et al.
Leukemia & Lymphoma|May 4, 2011
Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapyShiven B Patel, Ivana Gojo, Michael L Tidwell, et al.
Leukemia Research|November 25, 2011
Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experienceJason Bierenbaum, Amy J Davidoff, Yi Ning, et al.
British Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.
Oncology Nursing Forum|February 22, 2018
Early Identification of Intracranial Hemorrhage Using a Predictive NomogramFrances Chandler, Joyce Kane, Amanda Blackford, et al.
The American Journal of Dermatopathology|November 27, 2008
Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literatureGrace F Kao, Brooke Resh, Christine McMahon, et al.
Leukemia & Lymphoma|September 28, 2011
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemiaMichael W Evans, Anthony D Sung, Ivana Gojo, et al.
Leukemia & Lymphoma|September 13, 2014
Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic targetTai-Chung Huang, Jevon Cutler, Shubhada Bharne, et al.
Leukemia Research|July 21, 2007
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disordersJudith E Karp, Francis J Giles, Ivana Gojo, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Thoracic t(9;22)-positive granulocytic sarcoma as initial presentation of chronic myeloid leukemiaMhairi Mitchell, Doha Itani, Jonathan Gerber, et al.
Leukemia & Lymphoma|June 4, 2013
Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemiaYi Ning, Marilyn L Slovak, Roger A Schultz, et al.
Leukemia & Lymphoma|May 4, 2011
Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapyShiven B Patel, Ivana Gojo, Michael L Tidwell, et al.
Leukemia Research|November 25, 2011
Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experienceJason Bierenbaum, Amy J Davidoff, Yi Ning, et al.
British Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.
Oncology Nursing Forum|February 22, 2018
Early Identification of Intracranial Hemorrhage Using a Predictive NomogramFrances Chandler, Joyce Kane, Amanda Blackford, et al.
The American Journal of Dermatopathology|November 27, 2008
Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literatureGrace F Kao, Brooke Resh, Christine McMahon, et al.
Leukemia & Lymphoma|September 28, 2011
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemiaMichael W Evans, Anthony D Sung, Ivana Gojo, et al.
Leukemia & Lymphoma|September 13, 2014
Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic targetTai-Chung Huang, Jevon Cutler, Shubhada Bharne, et al.
Leukemia Research|July 21, 2007
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disordersJudith E Karp, Francis J Giles, Ivana Gojo, et al.
Pageof 13